🇺🇸 Human Papillomavirus vaccine in United States

18 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anxiety — 2 reports (11.11%)
  2. Cognitive Disorder — 2 reports (11.11%)
  3. Condition Aggravated — 2 reports (11.11%)
  4. Dizziness — 2 reports (11.11%)
  5. Drug Ineffective — 2 reports (11.11%)
  6. Drug Intolerance — 2 reports (11.11%)
  7. Foetal Exposure During Pregnancy — 2 reports (11.11%)
  8. Small For Dates Baby — 2 reports (11.11%)
  9. Abortion Spontaneous — 1 report (5.56%)
  10. Amnesia — 1 report (5.56%)

Source database →

Human Papillomavirus vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Human Papillomavirus vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Human Papillomavirus vaccine in United States?

Dalhousie University is the originator. The local marketing authorisation holder may differ — check the official source linked above.